ProfileGDS4177 / 1558076_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 34% 35% 41% 49% 39% 46% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated17.5634
GSM603099KU-812 non-treated17.8835
GSM603098KCL-22 Imatinib-treated22.341
GSM603097KCL-22 non-treated29.8749
GSM603102JURL-MK1 Imatinib-treated20.9339
GSM603101JURL-MK1 non-treated27.7646